BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4318535)

  • 1. Pitfalls in the preparation of monotypic agglutinating antisera for Bordetella pertussis.
    Holt LB
    J Med Microbiol; 1968 Nov; 1(2):169-80. PubMed ID: 4318535
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the serologic type in experimental immunity against B. Pertussis.
    Pusztai Z; Joó I
    Prog Immunobiol Stand; 1967; 3():309-14. PubMed ID: 4314431
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis.
    Dolby JM; Dolby DE
    Immunology; 1969 Jun; 16(6):737-47. PubMed ID: 4306784
    [No Abstract]   [Full Text] [Related]  

  • 7. Surveillance of whooping cough in Czechoslovakia. II. Incidence of antigenic types of B. pertussis in Czechoslovakia in the years 1966-1970.
    Maixnerová M; Burianová-Vysoká B; Stránský V
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):267-72. PubMed ID: 4342922
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic findings in oral pertussis vaccination].
    Kurz R; Mayr J; Höfler KH; Falk W; Rosanelli K
    Padiatr Padol; 1986; 21(1):53-9. PubMed ID: 2870453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of Bordetella pertussis antibodies by the latex slide test in comparison to agglutination and complement fixation test].
    Mochmann H; Hering L
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Feb; 130(2):143-8. PubMed ID: 4297441
    [No Abstract]   [Full Text] [Related]  

  • 11. [Passive protection tests in the mouse with pertussis immunoglobulin (author's transl)].
    Sabin S; Schwanig M
    Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):268-74. PubMed ID: 228513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype specificity of vaccine-induced immunity to pertussis.
    Preston NW; Carter EJ
    Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R155-6. PubMed ID: 1285135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenic value of the diphtheria-tetanus-pertussis trivaccine depending on the quantitative variations of its antigenic components. IV. Immunogenic properties of the pertussis compound].
    Andreescu V; Caffé I; Marion M; Pozsgi N; Stănică E; Stoian C; Kranzdorf H
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):487-92. PubMed ID: 4328575
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological surveys of antibodies against B. pertussis and B. parapertussis in some African and Asian countries.
    Maixnerova M; Buriánová B; Teplý V; Pecenka J; Serý V; Jezek Z
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):201-11. PubMed ID: 231624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bordetella pertussis serotypes in a whooping cough outbreak.
    Aftandelians RV; Connor JD
    Am J Epidemiol; 1974 May; 99(5):343-6. PubMed ID: 4363474
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
    Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K
    Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513
    [No Abstract]   [Full Text] [Related]  

  • 17. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological types of whooping cough bacteria and their connection with immunity in vaccinated children.
    Demina AA; Devyatkina NP; Voloshina LZ; Larina LI; Semina NA; Venglinskaya EA; Kostyukova KP
    J Hyg Epidemiol Microbiol Immunol; 1973 Mar; 17(3):304-15. PubMed ID: 4355335
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory correlates of protection and protective immunity to Bordetella pertussis.
    Shahin RD; Mink C; Wiedermann BL; Meade BD
    Adv Exp Med Biol; 1992; 327():287-92. PubMed ID: 1295347
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitoxin in human pertussis immune globulins.
    Ferngren H; Granström M
    J Biol Stand; 1986 Oct; 14(4):297-303. PubMed ID: 2881931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.